Advisory: Alerts incorrectly tagged to T Rowe Price Large-Cap Value Fund withdrawn
22/05/2025 11:29
Alerts on Instil Bio TIL.O and ImmuneOnco Biopharmaceuticals 1541.HK announcing clinical trial updates for Phase 2 trial of ‘2510 were inadvertently tagged to T Rowe Price Large-Cap Value Fund TILCX.O, an unrelated company and have been withdrawn. For the correct set of alerts, click nFWN3RU044 STORY_NUMBER: nFWN3RU0PH STORY_DATE: 22/05/2025 STORY_TIME: 10:01:01 GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on ImmuneOnco Biopharmaceuticals (Shanghai)
See all newsBrief: Immuneonco Biopharmaceuticals (Shanghai) To Subscribe For Wealth Management Product For Hk$87.5 Million
Brief: ImmuneOnCo Biopharmaceuticals (Shanghai) To Repurchase H Shares In Open Market
Brief: Immuneonco Biopharmaceuticals (Shanghai)Subscribes For Hk$212 Million Wealth Management Product
Brief: Immuneonco Biopharmaceuticals Shanghai Inc Posts FY Loss Attributable RMB218.6 Million
Brief: ImmuneOnco Biopharmaceuticals Shanghai Receives Approval From NMPA China For Investigational New Drug Application Of IMM0306S